Argon Pays $363M For Angiotech's Device Business
Angiotech Pharmaceuticals Inc. will sell its interventional products business to private equity-backed Argon Medical Devices Inc. for $362.5 million to pay off its debts and generate revenue, the medical device manufacturer...To view the full article, register now.
Already a subscriber? Click here to view full article